These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7996065)

  • 41. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
    Appel IM; Hop WC; Pieters R
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
    Tozuka M; Yamauchi K; Hidaka H; Nakabayashi T; Okumura N; Katsuyama T
    Ann Clin Lab Sci; 1997; 27(5):351-7. PubMed ID: 9303174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neurologic complications during chemotherapy of children with acute lymphoid leukemia].
    Kardos M; Grexa E; Kajtár P
    Orv Hetil; 1992 May; 133(18):1111-5. PubMed ID: 1579351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Fulminant hepatitis possibly caused by L-asparaginase during induction chemotherapy in a patient with acute lymphoblastic leukemia].
    Tsutsui M; Koike M; Komatsu N
    Rinsho Ketsueki; 2012 May; 53(5):531-4. PubMed ID: 22728556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New possibilities of treatment with PEG-L-asparaginase in patients with acute lymphoblastic leukemia sensitized to l-asparaginase E.coli and erwinase].
    Sikorska-Fic B; Makowska K; Rokicka-Milewska R
    Wiad Lek; 1998; 51 Suppl 4():233-6. PubMed ID: 10731974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical experiences with adrenaline as therapy and prevention of E. coli-L-asparaginase-induced anaphylaxis].
    Schwinger W; Urban C; Lackner H
    Klin Padiatr; 1992; 204(4):274-6. PubMed ID: 1518264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Transient diabetes mellitus with ketoacidosis in a child during the treatment of acute lymphoblastic leukemia with L-asparaginase].
    Skomra S; Przybylska T
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):31-2. PubMed ID: 1409032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperglycemia induced by chemotherapeutic agents used in acute lymphoblastic leukemia: report of three cases.
    Wang YJ; Chu HY; Shu SG; Chi CS
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):457-61. PubMed ID: 8281494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
    Plourde PV; Jeha S; Hijiya N; Keller FG; Silverman LB; Rheingold SR; Dreyer ZE; Dahl GV; Mercedes T; Lai C; Corn T
    Pediatr Blood Cancer; 2014 Jul; 61(7):1232-8. PubMed ID: 24436152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia].
    Sanz MA; Borrego D; Martín-Aragonés G; Martínez JA; Lorenzo I; Sanz G; Sayas MJ; Jarque I; Pastor E; Rafecas J
    Sangre (Barc); 1987; 32(4):476-81. PubMed ID: 3660187
    [No Abstract]   [Full Text] [Related]  

  • 51. L-Asparaginase and steroids-associated hypertriglyceridemia successfully treated with plasmapheresis in a child with acute lymphoblastic leukemia.
    Solano-Páez P; Villegas JA; Colomer I; Gutierrez MD; Fernandez-Teijeiro A
    J Pediatr Hematol Oncol; 2011 Apr; 33(3):e122-4. PubMed ID: 21399528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Superior sagittal sinus thrombosis following L-asparaginase therapy of acute lymphoblastic leukemia].
    Watanabe I; Sakai I; Matsumoto I
    Rinsho Ketsueki; 1992 Mar; 33(3):343-8. PubMed ID: 1578639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. L-asparaginase: an effective agent in the treatment of acute lymphoblastic leukemia.
    Kumar K; Kaur J; Walia S; Pathak T; Aggarwal D
    Leuk Lymphoma; 2014 Feb; 55(2):256-62. PubMed ID: 23662993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal glucose tolerance in children with acute leukemia. Effect of induction chemotherapy including L-asparaginase.
    Dacou-Voutetakis C; Palis J; Haidas S; Zannos-Mariolea L; Georgiopoulou P; Matsaniotis N
    Am J Pediatr Hematol Oncol; 1983; 5(2):139-46. PubMed ID: 6351658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.
    Yoshida H; Imamura T; Saito AM; Takahashi Y; Suenobu S; Hasegawa D; Deguchi T; Hashii Y; Kawasaki H; Endo M; Hori H; Suzuki N; Kosaka Y; Kato K; Yumura-Yagi K; Hara J; Oda M; Sato A; Horibe K;
    PLoS One; 2015; 10(8):e0136428. PubMed ID: 26317422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia.
    Soyer OU; Aytac S; Tuncer A; Cetin M; Yetgin S; Sekerel BE
    J Allergy Clin Immunol; 2009 Apr; 123(4):895-9. PubMed ID: 19081614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The adverse reaction of L-asparaginase and its prevention].
    Lai YH; Wu ZL; Chen FX
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):533-4. PubMed ID: 16083559
    [No Abstract]   [Full Text] [Related]  

  • 58. Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group.
    Liang DC; Hung IJ; Yang CP; Lin KH; Chen JS; Hsiao TC; Chang TT; Pui CH; Lee CH; Lin KS
    Leukemia; 1999 Feb; 13(2):155-60. PubMed ID: 10025887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia.
    Raetz EA; Salzer WL
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):554-63. PubMed ID: 20724951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
    Ridgway D; Neerhout RC; Bleyer A
    Cancer; 1989 Feb; 63(3):561-3. PubMed ID: 2643458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.